These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 106423)

  • 41. Biochemical correlates in mouse-killing behavior of the rat: brain acetylcholine and acetylcholinesterase after administration of delta9-tetrahydrocannabinol.
    Yoshimura H; Fujiwara M; Ueki S
    Brain Res; 1974 Dec; 81(3):567-70. PubMed ID: 4474050
    [No Abstract]   [Full Text] [Related]  

  • 42. Behavioral effects of serotonin neurotoxins: an overview.
    Messing RB
    Ann N Y Acad Sci; 1978 Jun; 305():480-96. PubMed ID: 360940
    [No Abstract]   [Full Text] [Related]  

  • 43. Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of delta9-tetrahydrocannabinol.
    Brown JE; Kassouny M; Cross JK
    Behav Biol; 1977 May; 20(1):104-10. PubMed ID: 869847
    [No Abstract]   [Full Text] [Related]  

  • 44. Physiological and behavioral effects of parachlorophenylalanine in the rat.
    Borbély AA; Huston JP; Waser PG
    Psychopharmacologia; 1973 Jul; 31(2):131-42. PubMed ID: 4269135
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of subchronic treatment with (-) 8 -trans-tetrahydrocannabinol ( 8 -THC) on food intake, body temperature, hexobarbital sleeping time and hexobarbital elimination in rats.
    Rating D; Broermann I; Honecker H; Kluwe S; Coper H
    Psychopharmacologia; 1972; 27(4):349-57. PubMed ID: 4648618
    [No Abstract]   [Full Text] [Related]  

  • 46. Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat.
    Murphy B; Nunes CN; Ronan JJ; Hanaway M; Fairhurst AM; Mellin TN
    J Appl Physiol (1985); 2000 Jul; 89(1):273-82. PubMed ID: 10904062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral delta9-tetrahydrocannabinol toxicity in rats treated for periods up to six months.
    Rosendrantz H; Sprague RA; Fleischman RW; Braude C
    Toxicol Appl Pharmacol; 1975 May; 32(2):399-417. PubMed ID: 1171539
    [No Abstract]   [Full Text] [Related]  

  • 48. Interactions of delta9-tetrahydrocannabinol with phenobarbital, ethanol and chlordiazepoxide.
    Pryor GT; Larsen FF; Carr JD; Braude MC
    Pharmacol Biochem Behav; 1977 Oct; 7(4):331-45. PubMed ID: 928491
    [No Abstract]   [Full Text] [Related]  

  • 49. Delta 9-tetrahydrocannabinol sensitization of the rat brain to direct cholinergic stimulation.
    Duncan GE; Dagirmanjian R
    Psychopharmacology (Berl); 1979 Feb; 60(3):237-40. PubMed ID: 108700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tolerance to the effects of delta9-THC on shuttle-box performance and body temperature.
    ten Ham M
    Pharmacol Biochem Behav; 1977 Feb; 6(2):183-5. PubMed ID: 859896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice.
    Wiley JL; Smith FL; Razdan RK; Dewey WL
    Eur J Pharmacol; 2005 Mar; 510(1-2):59-68. PubMed ID: 15740725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute and chronic effects on rats of (-) 1 -trans-tetrahydrocannabinol on unlearned motor tasks.
    Potvin RJ; Fried PA
    Psychopharmacologia; 1972; 26(4):369-78. PubMed ID: 4674065
    [No Abstract]   [Full Text] [Related]  

  • 53. Cannabis: review of behavioral effects in animals.
    Miller LL; Drew WG
    Psychol Bull; 1974 Jul; 81(7):401-17. PubMed ID: 4212977
    [No Abstract]   [Full Text] [Related]  

  • 54. Incorporation of uridine into ribonucleic acid in rat brain slices after 9 -tetrahydrocannabinol and cannabis.
    Roberge M; Witschi H
    Toxicol Appl Pharmacol; 1972 Nov; 23(3):455-8. PubMed ID: 5085458
    [No Abstract]   [Full Text] [Related]  

  • 55. Measurement of the three phases of muricidal behavior induced by delta9-tetrahydrocannabinol in isolated, fasting rats.
    Bac P; Pages N; Herrenknecht C; Paris M
    Physiol Behav; 1998 Mar; 63(5):815-20. PubMed ID: 9618004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On the accumulation of p-hydroxynorephedrine in noradrenaline neurons during chronic administration of amphetamine in the rat in relation to amphetamine tolerance.
    Lewander T
    Psychiatr Neurol Neurochir; 1972; 75(3):215-8. PubMed ID: 5064647
    [No Abstract]   [Full Text] [Related]  

  • 57. Similarities between delta9-tetrahydrocannabinol (delta9-THC) and reserpine-like drugs.
    Carder B; Deikel SM
    Behav Biol; 1976 Jul; 17(3):313-32. PubMed ID: 971187
    [No Abstract]   [Full Text] [Related]  

  • 58. Behavioral and electroencephalographic correlates of the chronic use of marijuana--a review.
    Fried PA
    Behav Biol; 1977 Oct; 21(2):163-96. PubMed ID: 334157
    [No Abstract]   [Full Text] [Related]  

  • 59. 2-Phenylethylamine as a possible mediator for delta9-tetrahydrocannabinol-induced stimulation.
    Sabelli HC; Vazquez AJ; Mosnaim AD; Madrid-Pedemonte L
    Nature; 1974 Mar; 248(5444):144-5. PubMed ID: 4274244
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment.
    Wu X; French ED
    Neuropharmacology; 2000 Jan; 39(3):391-8. PubMed ID: 10698005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.